Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Pricing Group Appointed By Northeast States To Meet With Manufacturers

Executive Summary

A working group representing eight northeastern states plans to meet with drug manufacturers to discuss prescription drug prices.

You may also be interested in...



Medicaid Rx Pool For Michigan, Vermont Shares PBM, Not Preferred Drug List

Michigan and Vermont plan to implement a Medicaid Rx purchasing pool through First Health Services, but the states will maintain separate preferred drug lists

Medicaid Rx Pool For Michigan, Vermont Shares PBM, Not Preferred Drug List

Michigan and Vermont plan to implement a Medicaid Rx purchasing pool through First Health Services, but the states will maintain separate preferred drug lists

Michigan Rx List Is More Restrictive Than Private Plans, Kaiser Study Says

The Michigan Medicaid preferred drug list is more restrictive in several therapeutic categories than other pharmacy benefit plans, a Kaiser Family Foundation study says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel